1 Market Overview

1.1 Product Overview and Scope of Immune Cell Therapy

1.2 Classification of Immune Cell Therapy by Type

1.2.1 Overview: Global Immune Cell Therapy Market Size by Type: 2022 Versus 2028

1.2.2 Global Immune Cell Therapy Revenue Market Share by Type in 2029

1.2.3 T Cell Therapy

1.2.4 Natural Killer (NK) Cell Therapy

1.2.5 Other

1.3 Global Immune Cell Therapy Market by Application

1.3.1 Overview: Global Immune Cell Therapy Market Size by Application: 2023 Versus 2029

1.3.2 Stomach Cancer

1.3.3 Lung Cancer

1.3.4 Colorectal Cancer

1.3.5 Esophageal Cancer

1.3.6 Pancreatic Cancer

1.3.7 Other

1.4 Global Immune Cell Therapy Market Size & Forecast

1.5 Market Drivers, Restraints and Trends

1.5.1 Immune Cell Therapy Market Drivers

1.5.2 Immune Cell Therapy Market Restraints

1.5.3 Immune Cell Therapy Trends Analysis

2 Company Profiles

2.1 Adaptimmune

2.1.1 Adaptimmune Details

2.1.2 Adaptimmune Major Business

2.1.3 Adaptimmune Immune Cell Therapy Product and Solutions

2.1.4 Adaptimmune Recent Developments and Future Plans

2.2 Altor Bioscience Corporation

2.2.1 Altor Bioscience Corporation Details

2.2.2 Altor Bioscience Corporation Major Business

2.2.3 Altor Bioscience Corporation Immune Cell Therapy Product and Solutions

2.2.4 Altor Bioscience Corporation Recent Developments and Future Plans

2.3 Cellectis

2.3.1 Cellectis Details

2.3.2 Cellectis Major Business

2.3.3 Cellectis Immune Cell Therapy Product and Solutions

2.3.4 Cellectis Recent Developments and Future Plans

2.4 Juno Therapeutics

2.4.1 Juno Therapeutics Details

2.4.2 Juno Therapeutics Major Business

2.4.3 Juno Therapeutics Immune Cell Therapy Product and Solutions

2.4.4 Juno Therapeutics Recent Developments and Future Plans

2.5 Kite Pharma

2.5.1 Kite Pharma Details

2.5.2 Kite Pharma Major Business

2.5.3 Kite Pharma Immune Cell Therapy Product and Solutions

2.5.4 Kite Pharma Recent Developments and Future Plans

2.6 Novartis

2.6.1 Novartis Details

2.6.2 Novartis Major Business

2.6.3 Novartis Immune Cell Therapy Product and Solutions

2.6.4 Novartis Recent Developments and Future Plans

2.7 Takara Bio

2.7.1 Takara Bio Details

2.7.2 Takara Bio Major Business

2.7.3 Takara Bio Immune Cell Therapy Product and Solutions

2.7.4 Takara Bio Recent Developments and Future Plans

2.8 Unum Therapeutics

2.8.1 Unum Therapeutics Details

2.8.2 Unum Therapeutics Major Business

2.8.3 Unum Therapeutics Immune Cell Therapy Product and Solutions

2.8.4 Unum Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Immune Cell Therapy Revenue and Share by Players (2023 & 2029)

3.2 Immune Cell Therapy Players Head Office, Products and Services Provided

3.3 Immune Cell Therapy Mergers & Acquisitions

3.4 Immune Cell Therapy New Entrants and Expansion Plans

4 Global Immune Cell Therapy Forecast by Region

4.1 Global Immune Cell Therapy Market Size by Region: 2023 VS 2029

4.2 Global Immune Cell Therapy Market Size by Region, (2023-2029)

4.3 North America

4.3.1 Key Companies of Immune Cell Therapy in North America

4.3.2 Current Situation and Forecast of Immune Cell Therapy in North America

4.3.3 North America Immune Cell Therapy Market Size and Prospect (2023-2029)

4.4 Europe

4.4.1 Key Companies of Immune Cell Therapy in Europe

4.4.2 Current Situation and Forecast of Immune Cell Therapy in Europe

4.4.3 Europe Immune Cell Therapy Market Size and Prospect (2023-2029)

4.5 Asia-Pacific

4.5.1 Key Companies of Immune Cell Therapy in Asia-Pacific

4.5.2 Current Situation and Forecast of Immune Cell Therapy in Asia-Pacific

4.5.3 Asia-Pacific Immune Cell Therapy Market Size and Prospect (2023-2029)

4.5.4 China

4.5.5 Japan

4.5.6 South Korea

4.6 South America

4.6.1 Key Companies of Immune Cell Therapy in South America

4.6.2 Current Situation and Forecast of Immune Cell Therapy in South America

4.6.3 South America Immune Cell Therapy Market Size and Prospect (2023-2029)

4.7 Middle East & Africa

4.7.1 Key Companies of Immune Cell Therapy in Middle East & Africa

4.7.2 Current Situation and Forecast of Immune Cell Therapy in Middle East & Africa

4.7.3 Middle East & Africa Immune Cell Therapy Market Size and Prospect (2023-2029)

5 Market Size Segment by Type

5.1 Global Immune Cell Therapy Market Forecast by Type (2023-2029)

5.2 Global Immune Cell Therapy Market Share Forecast by Type (2023-2029)

6 Market Size Segment by Application

6.1 Global Immune Cell Therapy Market Forecast by Application (2023-2029)

6.2 Global Immune Cell Therapy Market Share Forecast by Application (2023-2029)

7 Research Findings and Conclusion

8 Appendix

8.1 Methodology

8.2 Research Process and Data Source

8.3 Disclaimer

List of Tables

Table 1. Global Immune Cell Therapy Revenue by Type, (USD Million), 2023 VS 2029

Table 2. Global Immune Cell Therapy Revenue by Application, (USD Million), 2023 VS 2029

Table 3. Adaptimmune Corporate Information, Head Office, and Major Competitors

Table 4. Adaptimmune Major Business

Table 5. Adaptimmune Immune Cell Therapy Product and Solutions

Table 6. Altor Bioscience Corporation Corporate Information, Head Office, and Major Competitors

Table 7. Altor Bioscience Corporation Major Business

Table 8. Altor Bioscience Corporation Immune Cell Therapy Product and Solutions

Table 9. Cellectis Corporate Information, Head Office, and Major Competitors

Table 10. Cellectis Major Business

Table 11. Cellectis Immune Cell Therapy Product and Solutions

Table 12. Juno Therapeutics Corporate Information, Head Office, and Major Competitors

Table 13. Juno Therapeutics Major Business

Table 14. Juno Therapeutics Immune Cell Therapy Product and Solutions

Table 15. Kite Pharma Corporate Information, Head Office, and Major Competitors

Table 16. Kite Pharma Major Business

Table 17. Kite Pharma Immune Cell Therapy Product and Solutions

Table 18. Novartis Corporate Information, Head Office, and Major Competitors

Table 19. Novartis Major Business

Table 20. Novartis Immune Cell Therapy Product and Solutions

Table 21. Takara Bio Corporate Information, Head Office, and Major Competitors

Table 22. Takara Bio Major Business

Table 23. Takara Bio Immune Cell Therapy Product and Solutions

Table 24. Unum Therapeutics Corporate Information, Head Office, and Major Competitors

Table 25. Unum Therapeutics Major Business

Table 26. Unum Therapeutics Immune Cell Therapy Product and Solutions

Table 27. Global Immune Cell Therapy Revenue (USD Million) by Players (2023 & 2029)

Table 28. Global Immune Cell Therapy Revenue Share by Players (2023 & 2029)

Table 29. Immune Cell Therapy Players Head Office, Products and Services Provided

Table 30. Immune Cell Therapy Mergers & Acquisitions in the Past Five Years

Table 31. Immune Cell Therapy New Entrants and Expansion Plans

Table 32. Global Market Immune Cell Therapy Revenue (USD Million) Comparison by Region (2023 VS 2029)

Table 33. Global Immune Cell Therapy Revenue Market Share by Region (2023-2029)

Table 34. Key Companies of Immune Cell Therapy in North America

Table 35. Current Situation and Forecast of Immune Cell Therapy in North America

Table 36. Key Companies of Immune Cell Therapy in Europe

Table 37. Current Situation and Forecast of Immune Cell Therapy in Europe

Table 38. Key Companies of Immune Cell Therapy in Asia-Pacific

Table 39. Current Situation and Forecast of Immune Cell Therapy in Asia-Pacific

Table 40. Key Companies of Immune Cell Therapy in China

Table 41. Key Companies of Immune Cell Therapy in Japan

Table 42. Key Companies of Immune Cell Therapy in South Korea

Table 43. Key Companies of Immune Cell Therapy in South America

Table 44. Current Situation and Forecast of Immune Cell Therapy in South America

Table 45. Key Companies of Immune Cell Therapy in Middle East & Africa

Table 46. Current Situation and Forecast of Immune Cell Therapy in Middle East & Africa

Table 47. Global Immune Cell Therapy Revenue Forecast by Type (2023-2029)

Table 48. Global Immune Cell Therapy Revenue Forecast by Application (2023-2029)

List of Figures

Figure 1. Immune Cell Therapy Picture

Figure 2. Global Immune Cell Therapy Revenue Market Share by Type in 2029

Figure 3. T Cell Therapy

Figure 4. Natural Killer (NK) Cell Therapy

Figure 5. Other

Figure 6. Immune Cell Therapy Revenue Market Share by Application in 2029

Figure 7. Stomach Cancer Picture

Figure 8. Lung Cancer Picture

Figure 9. Colorectal Cancer Picture

Figure 10. Esophageal Cancer Picture

Figure 11. Pancreatic Cancer Picture

Figure 12. Other Picture

Figure 13. Global Immune Cell Therapy Market Size, (USD Million): 2023 VS 2029

Figure 14. Global Immune Cell Therapy Revenue and Forecast (2023-2029) & (USD Million)

Figure 15. Immune Cell Therapy Market Drivers

Figure 16. Immune Cell Therapy Market Restraints

Figure 17. Immune Cell Therapy Market Trends

Figure 18. Adaptimmune Recent Developments and Future Plans

Figure 19. Altor Bioscience Corporation Recent Developments and Future Plans

Figure 20. Cellectis Recent Developments and Future Plans

Figure 21. Juno Therapeutics Recent Developments and Future Plans

Figure 22. Kite Pharma Recent Developments and Future Plans

Figure 23. Novartis Recent Developments and Future Plans

Figure 24. Takara Bio Recent Developments and Future Plans

Figure 25. Unum Therapeutics Recent Developments and Future Plans

Figure 26. Global Immune Cell Therapy Revenue Market Share by Region (2023-2029)

Figure 27. Global Immune Cell Therapy Revenue Market Share by Region in 2029

Figure 28. North America Immune Cell Therapy Revenue (USD Million) and Growth Rate (2023-2029)

Figure 29. Europe Immune Cell Therapy Revenue (USD Million) and Growth Rate (2023-2029)

Figure 30. Asia-Pacific Immune Cell Therapy Revenue (USD Million) and Growth Rate (2023-2029)

Figure 31. South America Immune Cell Therapy Revenue (USD Million) and Growth Rate (2023-2029)

Figure 32. Middle East & Africa Immune Cell Therapy Revenue (USD Million) and Growth Rate (2023-2029)

Figure 33. Global Immune Cell Therapy Market Share Forecast by Type (2023-2029)

Figure 34. Global Immune Cell Therapy Market Share Forecast by Application (2023-2029)

Figure 35. Methodology

Figure 36. Research Process and Data Source